| Title |
Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial
|
|---|---|
| Published in |
Trials, September 2020
|
| DOI | 10.1186/s13063-020-04588-5 |
| Pubmed ID | |
| Authors |
Rosario Garcia-Vicuña, Francisco Abad-Santos, Isidoro González-Alvaro, Francisco Ramos-Lima, Jesús Sanz Sanz |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 230 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 230 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 31 | 13% |
| Student > Master | 23 | 10% |
| Other | 19 | 8% |
| Researcher | 19 | 8% |
| Student > Doctoral Student | 10 | 4% |
| Other | 37 | 16% |
| Unknown | 91 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 70 | 30% |
| Nursing and Health Professions | 18 | 8% |
| Psychology | 6 | 3% |
| Biochemistry, Genetics and Molecular Biology | 5 | 2% |
| Immunology and Microbiology | 5 | 2% |
| Other | 24 | 10% |
| Unknown | 102 | 44% |